Navigation Links
Athens Regional Medical Center Upgrades to Omnicell G4 Platform for Supply and Medication Management
Date:11/3/2011
mmission regulations for managing chain of custody for grafts and implants.
"Athens' decision to be an early adopter of the G4 platform demonstrates their commitment to bringing the latest automation technology to their patients and their clinical staff," said J. Christopher Drew, Omnicell senior vice president, field operations. "Taking advantage of the G4 platform's modular upgrade design, Athens will be able to extend the life of their original investment in Omnicell automation and avoid the disruption of whole product replacement."
About Athens Regional Medical Center
Athens Regional Medical Center is a 350-plus bed, full service regional referral center and is part of Athens Regional Health Services, an integrated system that provides for the healthcare needs of a 17-county service area in Northeast Georgia.
Athens Regional features nationally acclaimed, comprehensive cardiac, vascular and thoracic procedures including open heart surgery; cardiac catheterization and vascular labs; a full-spectrum of advanced surgical procedures; minimally invasive surgeries; a neurosurgery unit; a certified primary stroke care center; a free-standing outpatient radiology center and outpatient surgery center; adult and children's rehabilitation services; diagnostic and therapeutic oncology; Magnetic Resonance Imaging (MRI) and PET/CT Scanner; a neonatal intensive care unit, the Loran Smith Center for Cancer Support and the Breast Health Center.
About Omnicell
Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of automated and business information solutions enabling hospitals and healthcare systems to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seamless integration with a hospital's existing IT infrastructure, Omnicell solutions em
'/>"/>
| SOURCE Omnicell, Inc. Copyright©2010 PR Newswire. All rights reserved |
Related biology news :
1. ESHREs workshop on freezing of human sperm, eggs and embryos in Athens
2. Regional partnership to develop algal biofuels gets backing of San Diego leaders
3. University of Houston Site of Regional Center of Excellence
4. More pain means real gain in complex regional pain syndrome treatment
5. Announcing IOF Regionals 1st Asia-Pacific osteoporosis meeting
6. Singapore program to provide clinical insight; showcase for regional research
7. Register now for the IOF Regionals -- 1st Asia-Pacific Osteoporosis Meeting
8. New York City Regional Extension Center Selects Greenway
9. Cornells regional sun grant energy conference is May 24-26
10. The great pond experiment: Regional vs. local biodiversity
11. US greenhouse gas emissions and capture, regionally
Post Your Comments:
(Date:5/21/2013)... MA -- Over the past few decades, scientists have ... angioplasty balloons and metallic stents. While generally effective, each ... side effects. , A new study from MIT analyzes ... the benefits of angioplasty balloons and drug-releasing stents, but ... balloon is inflated in the artery for only a ...
(Date:5/20/2013)... are also commonly resistant to antimicrobial substances made ... in mBio , the online open-access journal ... colistin and host antimicrobials LL-37 and lysozyme, which ... mean that patients with life-threatening multi-drug resistant infections ... Colistin is a last-line drug for treating several ...
(Date:5/20/2013)... (NSF) planning grant will help establish the Center for ... the University of Illinois at Urbana-Champaign and Worcester Polytechnic ... devoted to research in drying moist, porous materials such ... products; chemical products; textiles; and biopharmaceuticals," said Hao Feng, ... human nutrition and the Illinois site director. , According ...
Breaking Biology News(10 mins):Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2... forest loss accounts for an estimated 17% of global ... to reduce these greenhouse gas fluxes to the atmosphere, ... is working to adopt a strategy for Reducing Emissions ... climate treaty. For tropical nations to be effective ...
... keeping a secret that may be the key to defeating ... at Rice University and Baylor College of Medicine (BCM) have ... for evading detection by the immune system. Comparing its ... first known appearance in the deadly "Spanish flu" outbreak of ...
... (Dec. 10, 2009) -- One of the promises of nanomedicine ... on diseased cells and get inside them. Nanoparticles can carry ... diagnostic tests; and they may eventually even enter a cell,s ... much luck as engineering. "Everything in nanomedicine right now ...
Cached Biology News:First phase of pan-tropical forest mapping debuting at COP15 2First phase of pan-tropical forest mapping debuting at COP15 3Study reveals H1N1 unexpected weakness 2Nanomedicine: Ending 'hit and miss' design 2Nanomedicine: Ending 'hit and miss' design 3(Date:5/21/2013)... results of a new study led by George ... evidence that nucleation of ice in small droplets ... water,s behavior at the nanoscale. The formation of ... scientific research question whose answer also has important ... , The crystallization of ice from supercooled water ...
(Date:5/21/2013)... The congress of the ERA-EDTA (European Renal Association ... congress in Europe on nephrology ... Istanbul to share their knowledge ... have been presented: / (1) Gupta, A ... REDUCES ESA USE" By SFP-iron administration, the ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 ... services company for clinical trials, announced today it ... Solutions, LLC. Clinverse’s ClinPay® FLS eClinical commerce ... payment process. SpendMD ™, Aggregate Spend ... solution for tracking and reporting transfer of value ...
(Date:5/21/2013)... ALBANY, New York , May 21, 2013 /PRNewswire/ ... published by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip ... Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, ... USD 2.4 billion in 2011 and is expected to ... 2018, to reach an estimated value of USD 4.7 ...
Breaking Biology Technology:Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5[0] Study led by GW professor provides better understanding of water's freezing behavior at nanoscale[0] ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials[0] Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC[0] The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research
... Nets to Prevent Serious Health Hazards ... Associated with Diethylene ... Pharmacopeial (USP),Convention today announced a revised Glycerin monograph in ... United States. The,revision strengthens safety nets to prevent serious ...
... The following was issued,today by the Greater Baltimore ... CEO, Greater Baltimore Committee, 140 company owners, executives ... The third annual Greater Baltimore Region Bioscience Awards, ... / Breakfast & Registration, 8:45 - 9:30 a.m. ...
... March 17 Mercury Therapeutics,Inc. (MTI), a ... protein,kinase targeted drugs, announces that it has ... advise on its strategic and partnering,opportunities, with ... shareholders., This appointment follows a significant ...
Cached Biology Technology:USP Announces Revised Glycerin Monograph 2USP Announces Revised Glycerin Monograph 3Greater Baltimore Committee to Announce Winners of Third Baltimore Region Bioscience Awards at Ceremonies on March 18 2Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 2Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 3Mouse monoclonal antibody raised against a partial recombinant ARHGEF11. NCBI Entrez Gene ID = ARHGEF11...
Mouse monoclonal antibody raised against a partial recombinant MYO7A. NCBI Entrez Gene ID = MYO7A...
... ,High Quality, Functionally-Validated, Ion Channel Cell Lines ... having a critical role in nerve and ... function in pain, CNS and the heart. ... investigated in therapeutic areas, such as neuropathic ...
... PrecisION Ion Channel Cell Lines ,High Quality, ... channels are well known for having a ... and consequently have a key function in ... modulate ion channels have been investigated in ...
Biology Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |